3G8O | Transcription | date | Feb 12, 2009 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Progesterone Receptor With Bound Pyrrolidine 1 | ||||||||||||||
authors | S.K.Thompson, D.G.Washburn, K.P.Madauss, S.P.Williams, E.L.Stewa | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Progesterone Receptor Chain: A, B Fragment: Ligand Binding Domain Synonym: Pr, Nuclear Receptor Subfamily 3 Group C Member 3 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Nr3c3, Pgr Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Bl21(De3) Expression_system_vector_type: Plasmid Expression_system_plasmid: Phis Gst | ||||||||||||||
symmetry | Space Group: P 1 21 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.90 Å | ||||||||||||
ligand | 30X, SO4 | enzyme |
| ||||||||||||
note | 3G8O supersedes 3G8N | ||||||||||||||
Primary reference | Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonists., Thompson SK, Washburn DG, Frazee JS, Madauss KP, Hoang TH, Lapinski L, Grygielko ET, Glace LE, Trizna W, Williams SP, Duraiswami C, Bray JD, Laping NJ, Bioorg Med Chem Lett. 2009 Aug 15;19(16):4777-80. Epub 2009 Jun 17. PMID:19595590 |
Data retrieval |
View 3G8O in 3D |
Visual 3D analysis of 3G8O |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3G8O |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |